Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Of Avapritinib In Patients With Indolent Or Smoldering Systemic Mastocytosis With Symptoms Inadequately Controlled With Standard Therapy

BLOOD(2019)

引用 12|浏览56
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要